Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

The formulation comparison between a biosimilar and a branded biologic. The cost, availability, and supply chain benefits of ...

The Food and Drug Administration has approved Fresenius Kabi's Biologics License Application for the denosumab biosimilars Conexxence (denosumab-bnht) and Bomyntra (denosumab-bnht). These ...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz. Byooviz (ranibizumab ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug ... at mealtimes for example – with ...

Stimulants are most commonly prescribed as a first-line treatment for ADHD. Examples of brand-name drugs include Vyvanse, Adderall, and Ritalin. However, negative side effects may be common.

Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease treatment Stelara launched two weeks ago, at US retail ...

Once the patent of a brand-name drug expires, manufacturers are free to create a bioequivalent drug. Generic drugs contain the same active ingredients as the brand-name product but may incorporate ...

ADHD-related TikTok content shapes viewer perceptions of the condition, but experts found that the videos often make inaccurate claims regarding symptoms and treatment, according to a study ...